Literature DB >> 6916769

Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway.

E F Plow.   

Abstract

Immunological detection of elastase, an enzyme present within leukocyte granules, has been used as a marker for polymorphonuclear leukocyte activation. Polymorphonuclear leukocytes contained 4.6 mug/10(7) cells, whereas erythrocytes, mononuclear cells, and platelets contained <1% of this level. In plasma that was separated from blood cells after 1 h at 22 degrees C, the mean level of elastase-related antigen in seven normal donors was 25+/-6 ng/ml. This level was unaltered by immediate separation of the plasma from the cells, by inclusion of protease inhibitors, or by anticoagulation of the plasma with either EDTA or acidcitrate-dextrose (the level in heparinized plasma was approximately threefold higher). In serum, the level of elastase-related antigen was 288+/-125 ng/ml, representing an 11.5-fold increase above plasma levels. The antigen detected in serum was immunochemically indistinguishable from the leukocyte enzyme. Release of elastase was observed when isolated polymorphonuclear leukocytes were added to nonanticoagulated platelet-rich or platelet-poor plasma, recalcified plasma, or to serum. Addition of a chelating agent to serum prevented elastase release, but calcium or magnesium did not induce release in the absence of plasma. Coagulation induced by addition of thrombin to plasma also failed to induce release. In whole blood or in anticoagulated plasma reconstituted with polymorphonuclear leukocytes and then recalcified, initial release of elastase occurred concomitantly with or slightly after clotting and reached maximal levels within 20-40 min after clot formation. The data indicates that early events in coagulation or other pathways that occur in parallel with coagulation induce leukocyte release. The release of elastase, a major fibrinolytic protease of leukocytes, from the cells provides a mechanism for this enzyme or other granule proteases to participate in physiological events.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6916769      PMCID: PMC371012          DOI: 10.1172/jci110482

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  The neutral proteases of human granulocytes. Isolation and partial characterization of two granulocyte collagenases.

Authors:  K Ohlsson; I Olsson
Journal:  Eur J Biochem       Date:  1973-07-16

2.  Differentiation of leukocytic fibrinolytic enzymes from plasmin by the use of plasmatic proteolytic inhibitors.

Authors:  G Hermann; P A Miescher
Journal:  Int Arch Allergy Appl Immunol       Date:  1965

3.  Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.

Authors:  E Plow; T S Edgington
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

4.  Optimum reaction conditions for human lactate dehydrogenase isoenzymes as they affect total lactate dehydrogenase activity.

Authors:  R J Gay; R B McComb; G N Bowers
Journal:  Clin Chem       Date:  1968-08       Impact factor: 8.327

5.  Properties of leucocytic protease.

Authors:  K Ohlsson
Journal:  Clin Chim Acta       Date:  1971-05       Impact factor: 3.786

6.  The use of p-nitrophenyl N-tert-butyloxycarbonyl-L-alaninate as substrate for elastase.

Authors:  L Visser; E R Blout
Journal:  Biochim Biophys Acta       Date:  1972-04-07

7.  Importance of neutrophilic leukocytes in the resolution of fibrin.

Authors:  M I Barnhart
Journal:  Fed Proc       Date:  1965 Jul-Aug

8.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

9.  Studies on human platelet protease activity.

Authors:  R L Nachman; B Ferris
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

10.  Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes.

Authors:  A Janoff; J Scherer
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  43 in total

1.  Gene expression profiling and association of circulating lactoferrin level with obesity-related phenotypes in Latino youth.

Authors:  J Y Kim; L E Campbell; G Q Shaibi; D K Coletta
Journal:  Pediatr Obes       Date:  2014-11-14       Impact factor: 4.000

2.  Biphasic changes in leukocytes induced by strenuous exercise.

Authors:  J B Hansen; L Wilsgård; B Osterud
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

3.  Plasma leucocyte elastase concentrations in smokers.

Authors:  C R Hind; H Joyce; G A Tennent; M B Pepys; N B Pride
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

4.  Capillary plasma elastase alpha 1-proteinase inhibitor in infected and non-infected neonates.

Authors:  R L Rodwell; K M Taylor; D I Tudehope; P H Gray
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

5.  Diagnosis and therapy of bacterial endophthalmitis, and serum levels of inflammation markers.

Authors:  V Huber-Spitzy; E Arocker-Mettinger; K Herkner; M Schiffbänker; L Georgiew; F J Steinkogler; G Grabner
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

6.  Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.

Authors:  S Idell; K K James; E G Levin; B S Schwartz; N Manchanda; R J Maunder; T R Martin; J McLarty; D S Fair
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

7.  Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.

Authors:  R M Senior; W F Skogen; G L Griffin; G D Wilner
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

8.  Inflammatory response, neutrophil activation, and free radical production after acute myocardial infarction: effect of thrombolytic treatment.

Authors:  D Bell; M Jackson; J J Nicoll; A Millar; J Dawes; A L Muir
Journal:  Br Heart J       Date:  1990-02

9.  Increased in vivo secretory activity of neutrophil granulocytes in patients with psoriasis and palmoplantar pustulosis.

Authors:  A Lundin; L Håkansson; R Hällgren; G Michaëlsson; P Venge
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

10.  Human plasma kallikrein releases neutrophil elastase during blood coagulation.

Authors:  Y T Wachtfogel; U Kucich; H L James; C F Scott; M Schapira; M Zimmerman; A B Cohen; R W Colman
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.